The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated. 

"This tool empowers patients and clinicians to work together, putting prevention at the center of care," said Ami B. Bhatt, MD, ACC chief innovation officer. "What we really want to do is create patient agency and reach as many people as we can for earlier detection of high blood pressure."

The algorithm, trained on more than 150,000 TTE studies, can calculate 18 different measurements regularly used in echocardiography

More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.

"We're constantly trying to keep our fingers on the pulse of what's happening in the real world," explained Joan Michaels, RN, director of the STS/ACC TVT Registry.  "This is not a trial; this is real-world experience."

Cardiology faces one of its most challenging decades ahead, with mounting pressures from workforce shortages, an aging population and declining reimbursements. To remain sustainable, practices are forced to rethink how care is delivered from the ground up.

New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.

Treatment with the device is consistently safe, but researchers still think more data is required before reaching any conclusions about its efficacy.